DOCUMENT RESOURCES FOR EVERYONE
Health & Medicine EU teriflunomide information

1. ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS1 2. 1.NAME OF THE MEDICINAL PRODUCTAUBAGIO 14 mg film-coated tablets2.QUALITATIVE AND QUANTITATIVE COMPOSITIONEach film-coated…

Documents Oncology guideline presentation

www.adaevidencelibrary.com Oncology Evidence-Based Nutrition Practice Guidelines Executive Summary of Recommendations American Dietetic Association Evidence Analysis Library®…

Health & Medicine pixantrone professional chemist information

Slide 1 Pixantrone maleate professional chemist information NDA 22481 By Ail Ibrahim Al Shafay (sec 5)(684) faculty of Tanta pharmacy ,Egypt [email protected] Generic name:…

Documents If Hp

CLINICAL PRACTICE GUIDELINE GI-001 version 4 ANAL CANAL CANCER Effective Date: October, 2013 The recommendations contained in this guideline are a consensus of the Alberta…

Documents Our purpose We enable people with life-altering conditions to lead better lives. A Guide to ...

Slide 1Our purpose We enable people with life-altering conditions to lead better lives. A Guide to www.ShireSupport.com Updated: Winter 2014 Shire Pharmaceuticals-SP Slide…

Documents IRESSA: A journey of experience from broad to biomarker populations Claire Watkins Global Product...

IRESSA: A journey of experience from broad to biomarker populations Claire Watkins Global Product Statistician, AstraZeneca EFSPI meeting on Oncology Basel, 24th June 2010…

Documents VARGATEF ® SLIDE KIT A short overview of VARGATEF ® in advanced adenocarcinoma of the lung...

Vargatef_medical slide-kit short_for download VARGATEF® Slide Kit A short overview of VARGATEF® in advanced adenocarcinoma of the lung Nintedanib is approved in the…

Documents A Guide to ShireSupport Updated: Summer 2013

Slide 1 A Guide to www.ShireSupport.com Updated: Summer 2013 Shire Pharmaceuticals-SP Our purpose We enable people with life-altering conditions to lead better lives. To…

Documents NDA#21-240 Histamine Dihydrochloride FDA Review December 13, 2000.

NDA#21-240 Histamine Dihydrochloride FDA Review December 13, 2000 CDER/DODP Review Team Medical Reviewers: Judy H. Chiao , M.D. Donna Griebel, M.D. (TL) Statisticians: Rajeshwari…